KIR3DL1 and leukemia: Although a definitive and easy-to-apply model for the evaluation of donor-recipient KIR alloreactivity is not currently available in clinical practice, the presence of a KIR mismatched have shown to positive impact the prognosis of leukemia patients after transplant, augmenting the NK-mediated GvL.